What Comes First: The Tools or the Discovery? Certainly the Right Tools Help

Microscope lenses closeup

 (DGIwire) — Over the last 30 years, advances in medical research technology have come fast and furious. This is especially true for testing equipment used to diagnose or screen for particular conditions prior to treatment. This progress will no doubt continue since clinical laboratory technology plays an integral role in healthcare.

One particularly promising area is automation and robotics, which increasingly frees scientists from the need to micromanage their experiments and results in greater productivity, lower laboratory costs and more creative time for researchers. Consequently, scientists can often set up, run and analyze the results of experiments in a fraction of the time previously needed with far less hands-on intervention.

Automation offers major benefits beyond the lab as well. At the corporate level— particularly for firms involved in drug discovery and clinical diagnostics—getting maximum efficiency out of every department, especially the research lab, is a constant issue. Thankfully, automation and robotics have significantly increased productivity and lowered costs.

With so many equipment options to consider today, choosing what equipment to use requires careful consideration. For instance, an academic research lab might opt to increase productivity by using equipment that eliminates a tedious task; a drug discovery unit in a pharmaceutical company will probably want to automate most phases of its research. Meanwhile, laboratories that work with DNA sequencing and genomics might have an even more intensive need for automation. That’s why many laboratory managers have consulted with a company called Harvard Bioscience before making these critical equipment-purchasing decisions.

Headquartered in Holliston, MA, Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products. The bulk of their products are scientific instruments used to advance life science research. These items are bought by thousands of researchers in over 100 countries through the convenience of their catalogs, their website and various distributors. Thanks to their manufacturing plants in the United States and internationally, Harvard Bioscience is able to work with customers worldwide.

Jeffrey A. Duchemin, President and CEO of Harvard Bioscience, says, “As one of the most comprehensive providers of research instrumentation, our goal is to make selection faster and easier, while providing laboratories with as many options as possible—thereby enabling them to do their jobs more effectively.”

Copyright-free content provided by DGIwire.